Overview


According to FutureWise analysis the market for veterinary diagnostics in 2023 is US$ 3.06 billion, and is expected to reach US$ 6.3 billion by 2031 at a CAGR of 9.40%.

Rising expenditure on animal healthcare, increased number of vet practitioners and rising prevalence of zoonotic diseases are some of the factors driving the veterinary diagnostics market growth. Moreover, a rise in the number of pet adoptions across the world shall further boost the market proliferation. As per the APPA survey, 2017, the canine population United States increased from over 69 million in 2012 to over 89 million in 2016 while the feline population witnessed a rise of over 6 million from 2012 to 2016. Additionally, the pet industry expenditure in the United States was projected to be over USD 70 million in 2017. 

Increased usage of latest technologies like fluorometric diagnostics, wearables, biosensors, nanotechnology and biomarkers along with in vitro diagnostics has significantly boosted the market growth. Furthermore, many key players are heavily investing on expanding their manufacturing facilities which shall increase the veterinary diagnostics market demand in developing regions. For example, Henry Schein in July 2017 announced a new website that provided e-commerce solutions that are improvised with an effective process for ordering medical, animal health and dental products for improving the user online experience. 

The emerging nations like India, Brazil are highly populated with farm and companion animals. However, the expenditure assigned to animal healthcare is relatively lower than developed nations. This is primarily due to a dearth of awareness amongst veterinary practitioners and pet owners regarding healthcare services provided to animals. Furthermore, veterinary diagnostic products are manufactured considering the North America and European markets which make them expensive for pet owner from developing markets, thereby posing a steep challenge to the market growth.  

  • IDEXX Laboratories
  • Abaxis
  • Zoetis
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Neogen Corporation
  • Heska Corporation
  • Virbac
  • Biomérieux SA
  • Idvet

(Note: The list of the major players will be updated with the latest market scenario and trends)

IDEXX announced its catalyst SDMA in January 2018 for analysing the functionality of kidney in companion animals. Furthermore, Randox Laboratories announced Vivalytic in April 2018 under the molecular diagnostics analyser division. Similarly, Zoetis in April 2018, established sustainable animal healthcare infrastructure in underdeveloped economies like Nigeria, Ethiopia and Uganda and this initiative was funded by the Bill & Melinda Gates Foundation.

By Product

  • Instruments
  • Consumables

By Technology

  • Immunodiagnostics
    • ELISA Tests
    • Allergen-specific Immunodiagnostic Tests
    • Immunoassay Analyzers
    • Other Immunodiagnostic Products
  • Clinical Biochemistry
    • Glucose Monitoring
    • Blood Gas & Electrolyte Analysis
  • Molecular Diagnostics
    • Polymer Chain Reaction (PCR) Tests
    • Microarrays
    • Other Molecular Diagnostic Products
  • Hematology
    • Hematology Cartridges
    • Hematology Analyzers
  • Urinalysis
    • Urinalysis Clips & Cartridges/ Panels
    • Urine Analyzers
    • Urine Test Strips
  • Other Veterinary Diagnostic Technologies

By Animal Type

  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals
  • Livestock Animals
    • Cattle
    • Pigs
    • Poultry
    • Other Livestock Animals

By End User

  • Veterinary Reference Laboratories
  • Veterinary Hospitals and Clinics
  • Point-of-care/In-house Testing
  • Research Institutes and Universities

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is classified into product, technology, animal type, end user and region. The product segment is fragmented into instruments and consumables. The consumables segment is predicted to hold the veterinary diagnostics market share owing to a rise in the usage of consumables in healthcare settings. The technology segment is categorised into clinical biochemistry, urinalysis, immunodiagnostics, molecular diagnostics and haematology. 

The animal type segment is bifurcated into livestock animals and companion animals. The livestock animals are further divided into cattle, poultry, pigs and horses while the companion animals are further classified into dogs and cats. The companion animal segment is anticipated to lead the market during the forecast period owing to a rise in the number of pet owners in developed nations like the United States where the annual expenditure for animal healthcare has escalated in recent years. The end user segment is fragmented into veterinary reference laboratories, veterinary hospitals and clinics, point of care/in-housing testing and research institutes and universities.

The North America region is anticipated to subjugate the market during the forecast period owing to a rise in the number of companion animal owners coupled with advancements in the veterinary healthcare infrastructure.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis 
  • Key market trends 
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Veterinary Diagnostics Market By Product, By Technology, By Animal Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Veterinary Diagnostics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Veterinary Diagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Market Analysis tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Global Veterinary Diagnostics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
        2. Consumables

  • 8.   Global Veterinary Diagnostics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunodiagnostics
         1.1. ELISA Tests
         1.2. Allergen-specific Immunodiagnostic Tests
         1.3. Immunoassay Analyzers
         1.4. Other Immunodiagnostic Products
        2. Clinical Biochemistry
         2.1. Glucose Monitoring
         2.2. Blood Gas and Electrolyte Analysis
        3. Molecular Diagnostics
         3.1. Polymer Chain Reaction (PCR) Tests
         3.2. Microarrays
         3.3. Other Molecular Diagnostic Products
        4. Hematology
         4.1. Hematology Cartridges
         4.2. Hematology Analyzers
        5. Urinalysis
         5.1. Urinalysis Clips and Cartridges/ Panels
         5.2. Urine Analyzers
         5.3. Urine Test Strips
        6. Other Veterinary Diagnostic Technologies

  • 9.   Global Veterinary Diagnostics Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Companion Animals
         1.1. Dogs
         1.2. Cats
         1.3. Horses
         1.4. Other Companion Animals
        2. Livestock Animals
         2.1. Cattle
         2.2. Pigs
         2.3. Poultry
         2.4. Other Livestock Animals

  • 10.   Global Veterinary Diagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Veterinary Reference Laboratories
        2. Veterinary Hospitals and Clinics
        3. Point-of-care/In-house Testing
        4. Research Institutes and Universities

  • 11.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.4. Rest of North America
        3. Market Size (USD Mn) Forecast for North America 2023-2031

  • 12.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (US$ Mn) Forecast for Latin America 2023-2031

  • 13.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        3. Market Size (US$ Mn) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. Korea
         2.5. India
         2.6. Australia and New Zealand
         2.7. ASEAN
         2.8. Rest of Asia Pacific
        3. Market Size (US$ Mn) Forecast for Asia Pacific 2023-2031

  • 15.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
         2.1. UAE
         2.2. South Africa
         2.3. Egypt
         2.4. Saudi Arabia
         2.5. Rest of MEA
        3. Market Size (US$ Mn) Forecast for MEA 2023-2031

  • 16.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •   1. IDEXX Laboratories
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abaxis
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview   
        3. Zoetis
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. QIAGEN N.V.
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Thermo Fisher Scientific
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Randox Laboratories
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Neogen Corporation
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Heska Corporation
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Virbac
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Biomérieux SA
         10.1. Company Overview (HQ, Business Segments, Employee Strength)
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Idvet
         11.1. Company Overview (HQ, Business Segments, Employee Strength)
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.  Competitive Intelligence and Competitive Matrix
    •   1. Competitive Intelligence
        2. Competitive Matrix

  • 19.  Major Deals and Strategic Alliances Analysis
    •   1. Joint ventures
        2. Mergers and acquisitions
        3. Licensing and partnerships
        4. Technology Collaborations
        5. Strategic Divestments
        6. Market Entry Strategies

  • 20.  Relevant Case Studies and Latest News Updates
    •   

  • 21.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 22.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients